Cardiol Therapeutics (TSE:CRDL) Shares Down 0.8% – Time to Sell?

Cardiol Therapeutics Inc. (TSE:CRDL)’s stock price fell 0.8% during mid-day trading on Wednesday . The stock traded as low as C$2.51 and last traded at C$2.53. 74,200 shares changed hands during mid-day trading, a decline of 48% from the average session volume of 141,666 shares. The stock had previously closed at C$2.55.

Cardiol Therapeutics Stock Up 4.4 %

The stock has a market cap of C$182.39 million, a price-to-earnings ratio of -5.68 and a beta of 0.70. The stock has a 50 day simple moving average of C$2.72 and a 200 day simple moving average of C$2.84. The company has a quick ratio of 6.84, a current ratio of 2.39 and a debt-to-equity ratio of 1.07.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.